BET | Jotup

EQS-News: MorphoSys AG Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

Retrieved on:

Wednesday, April 10, 2024

“Now, in 2024, we are pleased that Novartis is committing to the future of our promising pipeline.

Key Points:

“Now, in 2024, we are pleased that Novartis is committing to the future of our promising pipeline.
With its ample resources, additional scientific expertise and global footprint, Novartis can help accelerate pelabresib's potential worldwide.
Total revenues for the fourth quarter 2023 were € 59.0 million compared to € 81.6 million for the same period in 2022.
The decrease resulted first and foremost from prior year revenues stemming from the execution of an out-licensing agreement with Novartis.

ESPN BET Launches in North Carolina

Retrieved on:

Monday, March 11, 2024

ESPN BET, the official sportsbook of ESPN, launched today in North Carolina as the state’s legal sports betting market opened.

Key Points:

ESPN BET, the official sportsbook of ESPN, launched today in North Carolina as the state’s legal sports betting market opened.
ESPN BET, operated by PENN Entertainment (“PENN”) (Nasdaq: PENN), is now live in 18 states.
“We’re thrilled to bring ESPN BET to North Carolina, which marks the first new state launch under our ESPN partnership,” said Jay Snowden, CEO and President of PENN Entertainment.
We commend the North Carolina State Lottery Commission and all of the stakeholders involved in establishing this new legal sports betting market.”
"Launching ESPN BET for North Carolina fans is a pivotal moment," said Mike Morrison, Vice President of ESPN BET and ESPN Fantasy.

30-Year Media Veteran Michele Ghee Joins Athlete Fan Owned media company PlayersTV as First-Ever Chairwoman Spearheading a Bold New Era in Athlete Media and Distribution

Retrieved on:

Wednesday, March 27, 2024

DALLAS, March 27, 2024 /PRNewswire/ -- PlayersTV, the first ever athlete owned media network and content provider dedicated to lifestyle and culture, proudly announces the appointment of Michele Ghee, CEO of Expectant Media, as its first Chairwoman of the Board. With an esteemed career spanning three decades in media and entertainment, Ghee's extensive expertise will drive innovation and growth for PlayersTV. Furthermore, PlayersTV is extremely excited to welcome WNBA stars Alysha Clark and Chiney Ogwumike as investor owners, reinforcing the network's commitment to diversity and excellence.

Key Points:

With an esteemed career spanning three decades in media and entertainment, Ghee's extensive expertise will drive innovation and growth for PlayersTV.
As Chairwoman of PlayersTV, Ghee will steer the network's strategic direction, engaging athlete fans globally.
Her appointment marks a new era of growth and advancement for PlayersTV under her visionary leadership.
Ghee currently serves as CEO and Co-founder of Expectant Media, dedicated to supporting the growth of black-owned media.

Zenith Epigenetics Proudly Supports Rare Disease Day

Retrieved on:

Thursday, February 29, 2024

ZEN-3694 Expands Development to Include Multiple Rare Oncology Indications

Key Points:

Calgary, Alberta--(Newsfile Corp. - February 29, 2024) - Zenith Epigenetics Ltd. ("Zenith" or the "Company") announces its support of Rare Disease Day by highlighting our expanded development efforts of BET inhibitor ZEN-3694 for rare oncology diseases.
Rare Disease Day takes place every year on the last day of February, with this leap year day being the rarest of all Rare Disease Days.
This event is a global movement to promote equity in healthcare, and access to diagnosis and therapies for individuals living with rare diseases.
We are very pleased that NUT carcinoma patients receiving ZEN-3694 in clinical trial and compassionate use settings have benefitted from our drug," said Donald McCaffrey, CEO of Zenith Epigenetics.

Real Noise Reduction Technology: BET SLUMBUR Earplugs Debuts on Kickstarter

Retrieved on:

Monday, March 11, 2024

Kickstarter, Work, Hermann von Helmholtz, Health, Noise, Nano, Sleep, Hearing, Honeycomb, BET, Pressure, NRR, Personal protective equipment

Shenzhen, China, March 11, 2024 (GLOBE NEWSWIRE) -- BET SLUMBUR is excited to launch its groundbreaking real noise-reducing earplugs on Kickstarter now.

Key Points:

Shenzhen, China, March 11, 2024 (GLOBE NEWSWIRE) -- BET SLUMBUR is excited to launch its groundbreaking real noise-reducing earplugs on Kickstarter now.
These real noise reduction earplugs not only have real noise reduction technology but swiftly balance ear pressure in just 15 seconds to help you be happy to use it regularly due to their airy fit design.
BET SLUMBUR earplugs with Honeycomb Microporous Crystal Filter designed, the real noise reduction technology have provided a much better listening experience, and allow users to get a calm atmosphere without sacrificing the clarity of important voices at a safer level.
BET SLUMBUR's Honeycomb Microporous Crystal Filter doesn't just redefine the real noise reduction for earplugs; it prioritizes comfort and safeguards users' ears and hearing.

VYNE Reports 2023 Fourth Quarter and Year-End Financial Results and Provides Business Update

Retrieved on:

Thursday, February 29, 2024

Investigational New Drug, Psoriasis, FDA, Food, Conference, Vitiligo, Biomarker, Therapy, Patient, Drug discovery, IND, BET, Pharmaceutical industry

“We have made excellent progress with our VYN201 program and remain on track to initiate a Phase 2b trial in nonsegmental vitiligo next quarter.

Key Points:

“We have made excellent progress with our VYN201 program and remain on track to initiate a Phase 2b trial in nonsegmental vitiligo next quarter.
Trial startup activities are ongoing with patient enrollment expected to begin in the second quarter of 2024.
VYNE recently completed this study and achieved preliminary results consistent with its expectations at the outset of the study.
VYNE plans to submit the requested nonclinical information to the FDA by the end of the first quarter of 2024.

VYNE Therapeutics to Present Results of the Phase 1b Trial for VYN201 at the 2024 Global Vitiligo Foundation Annual Scientific Symposium

Retrieved on:

Tuesday, February 27, 2024

Vitiligo, Therapy, BET, Topical medication, Pharmaceutical industry

Oral presentation on March 7, 2024 will review positive safety and efficacy data for novel BET inhibitor VYN201

Key Points:

Oral presentation on March 7, 2024 will review positive safety and efficacy data for novel BET inhibitor VYN201
BRIDGEWATER, N.J., Feb. 27, 2024 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a clinical-stage biopharmaceutical company developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions, today announced that Dr. Iain Stuart, Chief Scientific Officer of the Company, will deliver an oral presentation featuring positive data from the Phase 1b trial of VYN201 in vitiligo at the 2024 Global Vitiligo Foundation Annual Scientific Symposium taking place in San Diego on March 7, 2024.
“We are pleased to have this opportunity to present the data from our Phase 1b trial with the vitiligo community at the Global Vitiligo Foundation Annual Scientific Symposium,” said Dr. Iain Stuart, Chief Scientific Officer of VYNE.
“The positive clinical data from the Phase 1b trial supports the advancement of VYN201 into a Phase 2b trial that we expect to initiate next quarter.”
A Phase 1 Study of the Safety, Pharmacokinetics, and Preliminary Efficacy of a Topical Pan-BD BET Inhibitor (VYN201) in Subjects with Active Non-Segmental Vitiligo (session #4)

One United Properties posts a consolidated turnover of 306.6 million euros and a gross profit of 105.9 million euros in 2023

Retrieved on:

Tuesday, February 27, 2024

AFI Cotroceni, Real estate, Growth, Infineon Technologies, Howell Township, New Jersey, IRR, One Tower, Policy, GDV, BET, BVB, Bucharest Stock Exchange, Security (finance)

The gross profit reached 105.9 million euros, a 9% increase excluding the one-off gain from Bucur Obor's bargain purchase of 19.1 million euros recognized in 2022.

Key Points:

The gross profit reached 105.9 million euros, a 9% increase excluding the one-off gain from Bucur Obor's bargain purchase of 19.1 million euros recognized in 2022.
The net profit amounted to 89.6 million euros, an increase of 8% compared to 2022, excluding the one-off.
Revenues from the residential segment reached 226.9 million euros in 2023, a 45% year-on-year increase driven by a diverse residential offering.
Based on the contracts signed with clients as of December 31st, 2023, One United Properties expects additional cash inflows of 295 million euros by 2025.

"Game 7" Available Now via EVEN

Retrieved on:

Monday, February 26, 2024

LOS ANGELES, Feb. 26, 2024 /PRNewswire/ -- IN THE BLACK MUSIC, a division of James DuBose's IN THE BLACK NETWORK, is set to release GAME 7 from its flagship artist; hip-hop lyricist, JOSHUA GUNN on 2/26/24! Executive produced by Gunn and DuBose, this project (which serves as Gunn's debut album) is a testament to the go-getters who've faced adversity in their walk through life. If you have ever been told you can't do something or had to see your way through the darkest of times and are constantly in search of something that speaks to your soul, inspires you to stay the course, while giving you that undeniable feeling that the world is truly yours, this album is for you!

Key Points:

At 15, he released his album "Perfection Xperiment 2" which features production from Grammy Award-winning producers 9th Wonder and Nicolay.
He's shared stages and collaborated with Kanye West, Ludacris, Snoop Dogg, Public Enemy and many others.
IN THE BLACK MUSIC, a division of IN THE BLACK NETWORK, is aligned with the same mission as its flagship company.
The premiere-free network streams directly on intheblacknetwork.tv or on a dedicated app that is available for download on iOS, Android devices, Apple TV, YouTube ROKU, LG and Samsung media players.

AROBS Transilvania Software shares will join the FTSE Russell indexes

Retrieved on:

Tuesday, February 20, 2024

Software, Travel, Multimedia, RON, Intelligent automation, Emerging market, Internet of things, Growth, Software architecture, EUR, Automation, BET, BVB, Bucharest Stock Exchange, Cryptocurrency

CLUJ-NAPOCA, Romania, Feb. 20, 2024 /PRNewswire/ -- The shares of AROBS Transilvania Software (BVB: AROBS), the largest technology company listed on the Bucharest Stock Exchange, will be included in the FTSE Russell Emerging Markets Index as of March 18, 2024.

Key Points:

CLUJ-NAPOCA, Romania, Feb. 20, 2024 /PRNewswire/ -- The shares of AROBS Transilvania Software (BVB: AROBS), the largest technology company listed on the Bucharest Stock Exchange, will be included in the FTSE Russell Emerging Markets Index as of March 18, 2024.
AROBS shares will be included in the FTSE Micro Cap index structure, as announced by the global index provider on February 16 following its quarterly review.
"We are thrilled that with AROBS inclusion in FTSE Russell, the exposure of Romanian entrepreneurial companies to global investors is increasing.
AROBS Transilvania Software provides software services and solutions in various industries, having approximately 70 partners of the Software Services business line located in Europe and America and more than 11.000 clients of the Software Products business lines from Europe and Asia.